MIND Institute, University of California Davis Health, 2825 50th Street, Sacramento, CA, USA.
Department of Psychiatry and Behavioral Sciences, University of California Davis Health, Sacramento, CA, USA.
J Neurodev Disord. 2021 Apr 8;13(1):13. doi: 10.1186/s11689-021-09361-6.
The purpose of this study was to evaluate expressive language sampling (ELS) as a procedure for generating spoken language outcome measures for treatment research in Down syndrome (DS). We addressed (a) feasibility, (b) practice effects across two short-term administrations, (c) test-retest reliability across two short-term administrations, (d) convergent and discriminant construct validity, and (e) considered comparisons across the conversation and narration contexts.
Participants were 107 individuals with DS between 6 and 23 years of age who presented with intellectual disability (IQ < 70). The utility of ELS procedures designed to collect samples of spoken language in conversation and narration were evaluated separately. Variables of talkativeness, vocabulary, syntax, utterance planning, and articulation quality, derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers), were considered. A 4-week interval was used to assess practice effects and test-retest reliability. Standardized direct assessments and informant report measures were collected to evaluate construct validity of the ELS variables.
Low rates of noncompliance were observed; youth who were under 12 years of age, had phrase-level speech or less, and had a 4-year-old developmental level or less were at particular risk for experiencing difficulty completing the ELS procedures. Minimal practice effects and strong test-retest reliability across the 4-week test-retest interval was observed. The vocabulary, syntax, and speech intelligibility variables demonstrated strong convergent and discriminant validity. Although significant correlations were found between the variables derived from both the conversation and narration contexts, some differences were noted.
The ELS procedures considered were feasible and yielded variables with adequate psychometric properties for most individuals with DS between 6 and 23 years old. That said, studies of outcome measures appropriate for individuals with DS with more limited spoken language skills are needed. Context differences were observed in ELS variables suggest that comprehensive evaluation of expressive language is likely best obtained when utilizing both contexts.
本研究旨在评估表达性语言取样(ELS)作为唐氏综合征(DS)治疗研究中产生口语语言结果测量的程序。我们解决了以下问题:(a)可行性;(b)两次短期管理之间的练习效应;(c)两次短期管理之间的测试-重测信度;(d)收敛和判别构念效度;(e)考虑了会话和叙述语境之间的比较。
参与者为 107 名年龄在 6 至 23 岁之间、智力残疾(IQ<70)的 DS 患者。分别评估了旨在收集会话和叙述中口语样本的 ELS 程序的实用性。从分段为 C 单元(即独立子句及其修饰语)的文字记录中提取的可交谈性、词汇量、句法、话语规划和发音质量等变量进行了考虑。使用 4 周的间隔来评估练习效应和测试-重测信度。收集了标准化的直接评估和知情者报告措施,以评估 ELS 变量的结构效度。
观察到低不遵守率;年龄在 12 岁以下、具有短语水平的言语或更少言语且发育水平为 4 岁或以下的年轻人特别难以完成 ELS 程序。在 4 周的测试-重测间隔内观察到最小的练习效应和很强的测试-重测信度。词汇量、句法和言语可理解性变量表现出很强的收敛和判别效度。尽管在会话和叙述语境中得出的变量之间发现了显著的相关性,但也注意到了一些差异。
考虑到的 ELS 程序是可行的,并且为大多数年龄在 6 至 23 岁之间的 DS 患者提供了具有足够心理测量特性的变量。话虽如此,仍需要对具有更有限口语技能的 DS 患者的适当结局测量进行研究。ELS 变量中的语境差异表明,当同时使用两种语境时,可能最好获得表达性语言的综合评估。